MedPath
NMPA Approval

Doxazosin Mesylate Tablets

国药准字H20000444

March 17, 2020

Drug Information

甲磺酸多沙唑嗪片

络欣平

络欣平

片剂

2mg(按C23H25N5O5计)

化学药品

March 17, 2020

Company Information

Applicant Company

Manufacturing Company

广东省普宁市下架山工业区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸多沙唑嗪片 - NMPA 批准文号 | MedPath